止血テスト:医療機器パイプライン分析

◆英語タイトル:Hemostasis Tests - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0192
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:301
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Hemostasis Tests – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Hemostasis Tests – Medical Devices Pipeline Assessment, 2019″ provides an overview of Hemostasis Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hemostasis Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hemostasis Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hemostasis Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Hemostasis Tests Overview 15
3 Products under Development 17
3.1 Hemostasis Tests – Pipeline Products by Stage of Development 17
3.2 Hemostasis Tests – Pipeline Products by Segment 18
3.3 Hemostasis Tests – Pipeline Products by Territory 19
3.4 Hemostasis Tests – Pipeline Products by Regulatory Path 20
3.5 Hemostasis Tests – Pipeline Products by Estimated Approval Date 21
4 Hemostasis Tests – Pipeline Products under Development by Companies 22
4.1 Hemostasis Tests Companies – Pipeline Products by Stage of Development 22
4.2 Hemostasis Tests – Pipeline Products by Stage of Development 24
5 Hemostasis Tests Companies and Product Overview 30
6 Hemostasis Tests- Recent Developments 163
7 Appendix 294

List of Tables
Table 1: Hemostasis Tests - Pipeline Products by Stage of Development 17
Table 2: Hemostasis Tests - Pipeline Products by Segment 18
Table 3: Hemostasis Tests - Pipeline Products by Territory 19
Table 4: Hemostasis Tests - Pipeline Products by Regulatory Path 20
Table 5: Hemostasis Tests - Pipeline Products by Estimated Approval Date 21
Table 6: Hemostasis Tests Companies - Pipeline Products by Stage of Development 22
Table 7: Hemostasis Tests - Pipeline Products by Stage of Development 24
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 9: Afinion PT Test - Capillary Blood - Product Status 30
Table 10: Afinion PT Test - Capillary Blood - Product Description 30
Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 31
Table 12: Coagulyzer 1 - Product Status 31
Table 13: Coagulyzer 1 - Product Description 32
Table 14: Coagulyzer 100 - Product Status 32
Table 15: Coagulyzer 100 - Product Description 33
Table 16: Coagulyzer 2 - Product Status 33
Table 17: Coagulyzer 2 - Product Description 34
Table 18: Coagulyzer 4 - Product Status 34
Table 19: Coagulyzer 4 - Product Description 35
Table 20: Fibrinogen Lyophilisat Coagulation Kit - Product Status 35
Table 21: Fibrinogen Lyophilisat Coagulation Kit - Product Description 36
Table 22: Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview 37
Table 23: Platelet Function Assay - Product Status 37
Table 24: Platelet Function Assay - Product Description 37
Table 25: Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
Table 26: AtomoRapid - Coagulation Monitoring - Product Status 38
Table 27: AtomoRapid - Coagulation Monitoring - Product Description 38
Table 28: BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
Table 29: Portable Diagnostic System - Hemostasis - Product Status 39
Table 30: Portable Diagnostic System - Hemostasis - Product Description 39
Table 31: Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
Table 32: Bio6 - Product Status 40
Table 33: Bio6 - Product Description 40
Table 34: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 35: Micropoc-CAT - Haemostasis Assay - Product Status 41
Table 36: Micropoc-CAT - Haemostasis Assay - Product Description 41
Table 37: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview 42
Table 38: Multiple Blood Analytes Test - Product Status 42
Table 39: Multiple Blood Analytes Test - Product Description 42
Table 40: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 41: Calibrated Automated Thrombogram - Thrombin Assay - Product Status 43
Table 42: Calibrated Automated Thrombogram - Thrombin Assay - Product Description 44
Table 43: STA Compact Max - NeoPTimal ISI - Product Status 44
Table 44: STA Compact Max - NeoPTimal ISI - Product Description 44
Table 45: STA Compact Max - Ristocetin Cofactor Assay - Product Status 45
Table 46: STA Compact Max - Ristocetin Cofactor Assay - Product Description 45
Table 47: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status 45
Table 48: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description 45
Table 49: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status 46
Table 50: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description 46
Table 51: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status 46
Table 52: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description 47
Table 53: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 47
Table 54: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 47
Table 55: STA-R Max - NeoPTimal ISI - Product Status 48

List of Figures
Figure 1: Hemostasis Tests - Pipeline Products by Stage of Development 17
Figure 2: Hemostasis Tests - Pipeline Products by Segment 18
Figure 3: Hemostasis Tests - Pipeline Products by Territory 19
Figure 4: Hemostasis Tests - Pipeline Products by Regulatory Path 20
Figure 5: Hemostasis Tests - Pipeline Products by Estimated Approval Date 21

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[止血テスト:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆